Tech Company Inital Public Offerings

PMV Pharmaceuticals IPO

PMV Pharmaceuticals, operating out of Cranbury, had an IPO event on 9/24/2020.

Transaction Overview

Announced On
Transaction Type
Proceeds Purpose
Management says it will use the net proceeds from the IPO as follows:to fund the Phase 1/2 development of PC14586;to support the development of our R273H program, including lead optimization and IND-enabling studies;or the development of our pipeline discovery programs; andthe remaining proceeds, if any, for other research and development opportunities, working capital and general corporate purposes.

Company Information

Company Status
Mailing Address
8 Clarke Dr. 3
Cranbury, NJ 08512
Email Address
PMV Pharmaceuticals (Nasdaq: PMVP) is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV combines unique biological understanding with pharmaceutical development focus.
PMV Pharmaceuticals LinkedIn Company Profile
Social Media
PMV Pharmaceuticals Company Twitter Account
Company News
PMV Pharmaceuticals News
PMV Pharmaceuticals on Facebook
PMV Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
David Mack
  David Mack LinkedIn Profile  David Mack Twitter Account  David Mack News  David Mack on Facebook
Chief Medical Officer
Leila Alland
  Leila Alland LinkedIn Profile  Leila Alland Twitter Account  Leila Alland News  Leila Alland on Facebook
Chief Operating Officer
Winston Kung
  Winston Kung LinkedIn Profile  Winston Kung Twitter Account  Winston Kung News  Winston Kung on Facebook
Vice President
Thomas Davis
  Thomas Davis LinkedIn Profile  Thomas Davis Twitter Account  Thomas Davis News  Thomas Davis on Facebook
Vice President
Melissa Dumble
  Melissa Dumble LinkedIn Profile  Melissa Dumble Twitter Account  Melissa Dumble News  Melissa Dumble on Facebook
Vice President
Binh Vu
  Binh Vu LinkedIn Profile  Binh Vu Twitter Account  Binh Vu News  Binh Vu on Facebook
VP - Regulatory Affairs
Deepika Jalota
  Deepika Jalota LinkedIn Profile  Deepika Jalota Twitter Account  Deepika Jalota News  Deepika Jalota on Facebook



Browse more venture capital transactions:

Prev: 9/24/2020: Silverback Therapeutics venture capital transaction
Next: 9/24/2020: Libra Therapeutics venture capital transaction


Share this article


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary